Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Okubo

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2025
Lineage-specific transcription factor landscape of thymic neuroendocrine tumorsSeiji Omura, Yutaka Kurebayashi, Junko Hamamoto, et al.
Experimental & Molecular Medicine|March 3, 2024
Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretabilityKen Takasawa, Ken Asada, Syuzo Kaneko, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2025
Prediction recurrence in stage I epidermal growth factor receptor-mutated non-small cell lung cancer using multi-modal dataAkiko Tateishi, Hidehito Horinouchi, Nobuji Kouno, et al.
Molecular Cancer|September 1, 2024
Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targetsKen Asada, Syuzo Kaneko, Ken Takasawa, et al.
Molecular Cancer|June 11, 2024
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterationsSyuzo Kaneko, Ken Takasawa, Ken Asada, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2025
Lineage-specific transcription factor landscape of thymic neuroendocrine tumorsSeiji Omura, Yutaka Kurebayashi, Junko Hamamoto, et al.
Experimental & Molecular Medicine|March 3, 2024
Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretabilityKen Takasawa, Ken Asada, Syuzo Kaneko, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2025
Prediction recurrence in stage I epidermal growth factor receptor-mutated non-small cell lung cancer using multi-modal dataAkiko Tateishi, Hidehito Horinouchi, Nobuji Kouno, et al.
Molecular Cancer|September 1, 2024
Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targetsKen Asada, Syuzo Kaneko, Ken Takasawa, et al.
Molecular Cancer|June 11, 2024
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterationsSyuzo Kaneko, Ken Takasawa, Ken Asada, et al.
Pageof 9